Search Result "simvastatin and ER niacin combination tablet"

Simultaneous Quantification of Simvastatin and Simvastatin Acid in Human Plasma with a Highly Sensitive LC-ESI-MS/MS Method: Application to a Pharmacokinetic Study in Healthy Chinese Volunteers with a Fixed Dose of Simvastatin and Extended-Release Niacin Combination Tablet

Journal: Current Pharmaceutical Analysis
Volume: 12 Issue: 2 Year: 2016 Page: 96-106
Author(s): Qiuying Li,Yan Yang,Guobing Shi,Jie Zhang,Guoqing Li,Yin Sui,Yunbiao Tang,Jingkai Gu

Niacin: From Mechanisms of Action to Therapeutic Uses

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2010 Page: 204-217
Author(s): M.A Al-Mohaissen, S.C. Pun, J.J Frohlich

The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3094-3106
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold

Combination of Fenofibrate with Non-Statin Drug Regimens

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 3401-3416
Author(s): A. P. Agouridis, T. D. Filippatos, C. S. Derdemezis, D. P. Mikhailidis, M. S. Elisaf

Pleiotropic Effects of Nicotinic Acid: Beyond High Density Lipoprotein Cholesterol Elevation

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 4 Year: 2011 Page: 385-400
Author(s): Matilda Florentin, Evangelos N. Liberopoulos, Anastazia Kei, Dimitri P. Mikhailidis, Moses S. Elisaf

Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3858-3868
Author(s): Manfredi Rizzo, Marcin Barylski, Ali A. Rizvi, Giuseppe Montalto, Dimitri P. Mikhailidis, Maciej Banach

Review Article

Exploring the Management of Statin Intolerant Patients: 2016 and Beyond

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 6 Year: 2016 Page: 523-533
Author(s): Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis

How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with Type 2 Diabetes?

Journal: Vascular Disease Prevention
Volume: 3 Issue: 4 Year: 2006 Page: 335-344
Author(s): Sheila A. Doggrell

What Restricts the Clinical Use of Nicotinic Acid?

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 4 Year: 2011 Page: 521-530
Author(s): Anastazia Kei, Evangelos N. Liberopoulos, Moses S. Elisaf

Lipid Management for the Prevention of Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 852-860
Author(s): Juergen R. Schaefer

Previous   Next

Go To   Results 1 - 1 of 33

Apply Filters

Volume Years

Content Type


© 2024 Bentham Science Publishers | Privacy Policy